Medications for Gastroenteropancreatic Neuroendocrine Tumor

3 results
  • afinitor - everolimus tablet

    (Everolimus)
    Novartis Pharmaceuticals Corporation
    Afinitor treats advanced HR+/HER2- breast cancer (with exemestane), progressive neuroendocrine tumors (pancreatic, GI, or lung), advanced renal cell carcinoma, and tuberous sclerosis complex (TSC)-associated renal angiomyolipoma, SEGA, and partial-onset seizures in adults and pediatric patients.
  • lutathera - lutetium lu 177 dotatate injection

    (Lutetium Lu 177 Dotatate)
    Advanced Accelerator Applications Usa, Inc
    Lutathera treats somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs) — including foregut, midgut, and hindgut types — in adults and pediatric patients 12 years and older.
  • somatuline depot - lanreotide acetate injection

    (Lanreotide Acetate)
    Ipsen Biopharmaceuticals, Inc.
    Somatuline Depot treats acromegaly in patients with inadequate response to surgery/radiotherapy, improves progression-free survival in adults with unresectable or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs), and reduces rescue therapy frequency in adults with carcinoid syndrome.